Biotechnology: Pharmaceutical Preparations Stocks
397 biotechnology: pharmaceutical preparations stocks ranked by market capitalization. Updated October 11, 2026.
MetaCap tracks 397 US-listed companies in the Biotechnology: Pharmaceutical Preparations industry, part of the broader Health Care sector, worth a combined $4.64T. The largest biotechnology: pharmaceutical preparations stocks are Eli Lilly (LLY, $1.1T), Johnson & Johnson (JNJ, $630.0B) and AbbVie (ABBV, $488.6B). The biggest company alone accounts for about 23% of the industry's total market value, and the median member is worth $13.6B. On the latest trading day, 41 of 50 biotechnology: pharmaceutical preparations stocks shown were higher, with an average move of +1.69%; Spyre Therapeutics (SYRE) led with a 7.25% gain.
Summary generated from market data by MetaCap's automated system. Methodology
Largest biotechnology: pharmaceutical preparations stocks by market cap
| # | Symbol | Company | Price | % Change | Volume | Market Cap |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1,179.27 | +0.83% | 1.38M | $1.05T |
| 2 | JNJ | Johnson & Johnson | 261.44 | +1.93% | 5.46M | $630.04B |
| 3 | ABBV | AbbVie Inc. | 276.47 | +1.49% | 4.26M | $488.55B |
| 4 | MRK | Merck & Company Inc. | 145.60 | +2.26% | 8.00M | $359.22B |
| 5 | NVS | Novartis AG | 143.75 | +0.45% | 1.90M | $273.23B |
| 6 | AZN | AstraZeneca PLC | 159.20 | +0.26% | 2.06M | $246.90B |
| 7 | ABT | Abbott Laboratories | 99.60 | +1.13% | 6.96M | $172.35B |
| 8 | NVO | Novo Nordisk A/S | 38.64 | +1.20% | 9.38M | $170.57B |
| 9 | PFE | Pfizer Inc. | 28.28 | +1.65% | 22.60M | $161.19B |
| 10 | BMY | Bristol-Myers Squibb Company | 59.12 | -0.77% | 9.25M | $120.77B |
| 11 | SNY | Sanofi ADS | 40.07 | -0.40% | 2.10M | $96.01B |
| 12 | GSK | GSK plc ADR | 46.50 | -0.09% | 8.43M | $93.16B |
| 13 | TAK | Takeda Pharmaceutical Company Limited ADR | 18.73 | +1.13% | 2.04M | $59.83B |
| 14 | TEVA | Teva Pharmaceutical Industries Limited | 41.10 | +4.71% | 14.36M | $47.93B |
| 15 | ONC | BeOne Medicines Ltd. ADR | 354.47 | +1.24% | 191.37K | $40.33B |
| 16 | ALNY | Alnylam Pharmaceuticals Inc. | 232.68 | +3.63% | 859.92K | $31.13B |
| 17 | ZTS | Zoetis Inc. Class A | 74.81 | +2.37% | 2.89M | $30.91B |
| 18 | ROIV | Roivant Sciences Ltd. | 35.44 | +3.60% | 5.53M | $25.60B |
| 19 | UTHR | United Therapeutics Corporation | 549.16 | +3.07% | 562.00K | $23.55B |
| 20 | GMAB | Genmab A/S ADS | 37.07 | +2.83% | 2.33M | $22.79B |
| 21 | INSM | Insmed Incorporated | 100.60 | +0.12% | 2.47M | $21.97B |
| 22 | VTRS | Viatris Inc. | 17.64 | +1.15% | 8.83M | $20.26B |
| 23 | ASND | Ascendis Pharma A/S | 229.23 | +2.94% | 815.73K | $15.08B |
| 24 | JAZZ | Jazz Pharmaceuticals plc | 218.42 | -1.81% | 1.29M | $14.18B |
| 25 | SMMT | Summit Therapeutics Inc. | 17.59 | +2.45% | 5.75M | $14.03B |
| 26 | CORT | Corcept Therapeutics Incorporated | 121.19 | +2.24% | 496.52K | $13.10B |
| 27 | BBIO | BridgeBio Pharma Inc. | 65.35 | +0.48% | 1.85M | $12.78B |
| 28 | ELAN | Elanco Animal Health Incorporated | 22.92 | +1.69% | 2.52M | $11.45B |
| 29 | MDGL | Madrigal Pharmaceuticals Inc. | 471.75 | -1.08% | 312.98K | $10.90B |
| 30 | PTGX | Protagonist Therapeutics Inc. | 143.73 | +2.73% | 761.53K | $9.30B |
| 31 | ARWR | Arrowhead Pharmaceuticals Inc. | 62.75 | +3.31% | 2.77M | $8.86B |
| 32 | AXSM | Axsome Therapeutics Inc. | 168.35 | -1.02% | 894.48K | $8.82B |
| 33 | TGTX | TG Therapeutics Inc. | 55.37 | +3.81% | 1.62M | $8.48B |
| 34 | SYRE | Spyre Therapeutics Inc. | 85.69 | +7.25% | 1.12M | $8.01B |
| 35 | ABVX | Abivax SA ADR | 88.15 | -1.01% | 884.88K | $7.69B |
| 36 | IONS | Ionis Pharmaceuticals Inc. | 45.28 | +4.57% | 4.86M | $7.52B |
| 37 | PRAX | Praxis Precision Medicines Inc. | 259.86 | -1.40% | 517.23K | $7.26B |
| 38 | AMRX | Amneal Pharmaceuticals Inc. Class A | 19.91 | +1.32% | 1.68M | $6.93B |
| 39 | ALKS | Alkermes plc | 40.61 | +1.25% | 1.63M | $6.81B |
| 40 | RYTM | Rhythm Pharmaceuticals Inc. | 90.78 | +1.27% | 1.41M | $6.25B |
| 41 | KNSA | Kiniksa Pharmaceuticals International plc Class A | 79.78 | +1.31% | 430.27K | $6.22B |
| 42 | BLTE | Belite Bio Inc ADR | 154.49 | +1.29% | 158.40K | $6.22B |
| 43 | LGND | Ligand Pharmaceuticals Incorporated | 301.81 | +2.31% | 183.04K | $6.02B |
| 44 | ERAS | Erasca Inc. | 16.03 | +3.69% | 7.59M | $5.61B |
| 45 | MIRM | Mirum Pharmaceuticals Inc. | 86.01 | +5.73% | 1.14M | $5.58B |
| 46 | PTCT | PTC Therapeutics Inc. | 64.70 | +3.42% | 1.17M | $5.40B |
| 47 | COGT | Cogent Biosciences Inc. | 31.00 | +3.06% | 2.52M | $5.38B |
| 48 | GRFS | Grifols S.A. ADR | 7.46 | +0.67% | 330.56K | $5.08B |
| 49 | TVTX | Travere Therapeutics Inc. | 52.13 | +0.16% | 1.17M | $4.91B |
| 50 | DNTH | Dianthus Therapeutics Inc. | 82.37 | -0.07% | 738.86K | $4.61B |
Frequently asked questions
- How many biotechnology: pharmaceutical preparations stocks are there?
- MetaCap tracks 397 US-listed stocks in the Biotechnology: Pharmaceutical Preparations industry, with a combined market value of about $4.64T.
- What is the largest biotechnology: pharmaceutical preparations company?
- Eli Lilly (LLY) is the largest biotechnology: pharmaceutical preparations stock by market capitalization, at about $1.05T.
- What sector is the biotechnology: pharmaceutical preparations industry in?
- The Biotechnology: Pharmaceutical Preparations industry belongs to the Health Care sector. Sectors are broad groupings of related industries; industries group companies with very similar products or business models.
- How are biotechnology: pharmaceutical preparations stocks doing today?
- As of October 11, 2026, the Biotechnology: Pharmaceutical Preparations industry is up 1.27% on a market-cap-weighted basis.
Explore more
Prices as of Oct 11, 4:40 AM EDT. Market data is delayed at least 15 minutes and provided for informational purposes only. Not investment advice. Full disclaimer